Current Projects

Analysis and Publications (A&P)

Principal InvestigatorProposal Title
Gaurav Gulati, Tufts Medical CenterKidney Disease, Right Ventricle Dysfunction and Outcomes in Older LVAD Recipients
Michael Kiernan, Tufts Medical CenterPartial Myocardial Recovery And Long-Term Post LVAD Outcomes
Jeff Teuteberg/Sung-Min Cho, Stanford University/Johns Hopkins UniversityEpidemiology and Outcomes of Patients Bridged to Heart Transplant with Durable LVAD Support    
Indranee Rajapreyar, Tufts Medical CenterLate Right Heart Failure after Left Ventricular Assist Device Implantation: Impact on Outcomes and Association with Adverse Events Beyond One Year
Todd Dardas, University of WashingtonModeling days alive and out of hospital for durable left ventricular assist device support
Daniel Goldstein, Montefiore Medical CenterExamining the Adverse Events Profile of BTT/BTC Patients after the UNOS Allocation Changes
James Mehaffey, West Virginia University Mortality risk prediction for patients who receive a HeartMate3 left ventricular assistance device
Humera Ahmed, Children’s Hospital of PhiladelphiaExplainable Machine Learning To Assess The Risk For Right Heart Failure During Pediatric Left Ventricular Assist Device Placement
Waldemar Carlo, University of Alabama at BirminghamComparison of Outcomes Between Heartmate 3 and Cardiac Transplantation in Adolescents with Dilated Cardiomyopathy
Joseph Rossano, Children’s Hospital of PhiladelphiaLong Term Ventricular Assist Devices in Children

Participant User File (PUF)

Principal InvestigatorProposal Title
Erin Schumer Outcomes of Patients with Left Ventricular Assist Device Based on Distance From Implant Center
Harikesh Subramanian Effects Of Social Determinants Of Health (Sdoh) On Complications After VAD Implantation: Exploration Of The ZIP Code And Outcomes
Omar Saeed, Montefiore Medical Center, Albert EinsteinNeurologic Dysfunction in Patients with Contemporary Magnetically Levitated Left Ventricular Assist Devices
Paul Tang, Mayo ClinicPreoperative Passive Cardiac Index Determines Left Ventricular Assist Device Outcomes
Lauren Cooper, Northwell HealthGuideline Directed Medical Therapy (GDMT) for Heart Failure in Patients with Durable Left Ventricular Assist Devices (LVAD)
Donna Mancini, Icahn School of Medicine at Mount SinaiAdvanced Chronic Kidney Disease and Ventricular Assist Device Outcomes: An Analysis of the STS INTERMACS Database
Vinod Thourani, Piedmont HealthcareCharacterization of the natural history of aortic regurgitation in LVAD patients: an INTERMACS analysis
Leora Balsam, UMass Chan Medical SchoolINTERMACS Registry Trends and Outcomes after Heartmate 3 Left Ventricular Assist Device Implantation: The Impact of Surgical Approach
Keith Aaronson, University of MichiganA novel model to predict Gastrointestinal bleeding after a Heartmate 3 LVAD implantation
Eric Adler, University of California-San Diego             Machine learning for prognostication in advanced heart failure
Jerry Estep, Cleveland ClinicPredictors of hospital readmission burden and survival analysis in patients with contemporary continuous flow left ventricular assist device (CF-LVAD)
Lucian Lozonschi  Medical University of South CarolinaVentricular arrhythmia post cf-left ventricular assist device placement – Trends within the STS Intermacs in the contemporary era
Duc Thinh Pham, Northwestern UniversityRisk assessment model for wait list mortality in left ventricular assist device patients
Edward Grandin, Beth Israel Deaconess Medical CenterAssessing the impact of beta-blockers on late right heart failure and survival after left ventricular assist device implantation